We are live on ! Find out more
SRC

Shufro Rose & Co Portfolio holdings

AUM $1.47B
1-Year Est. Return 19.38%
This Fund
S&P 500
This Quarter Est. Return
+0.94%
1 Year Est. Return
+19.38%
3 Year Est. Return
+47.49%
5 Year Est. Return
+55.37%
10 Year Est. Return
+200.77%
AUM
$904M
AUM Growth
+$9.28M
Cap. Flow
+$5.82M
Cap. Flow %
0.64%
Top 10 Hldgs %
31.24%
Holding
285
New
14
Increased
34
Reduced
142
Closed
18

Sector Composition

Rank Sector Weight
1 Technology 20.12%
2 Industrials 18.12%
3 Consumer Discretionary 12.9%
4 Healthcare 11.73%
5 Financials 9.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGYS icon
101
Agilysys
AGYS
$2.78B
$1.19M 0.13%
113,285
-5,575
-5% -$60.2K
SEB icon
102
Seaboard Corp
SEB
$4.52B
$1.15M 0.13%
402
+7
+2% +$20.5K
MDT icon
103
Medtronic
MDT
$107B
$1.12M 0.12%
12,953
-372
-3% -$30.1K
AVX
104
DELISTED
AVX Corporation
AVX
$1.12M 0.12%
82,641
-3,025
-4% -$39.8K
XYL icon
105
Xylem
XYL
$28.5B
$1.11M 0.12%
24,793
-795
-3% -$34.5K
FRA icon
106
BlackRock Floating Rate Income Strategies Fund
FRA
$381M
0
MRK icon
107
Merck
MRK
$324B
$1.07M 0.12%
19,496
-2,447
-11% -$130K
TDAY
108
USA Today Co
TDAY
$1.23B
$1.06M 0.12%
58,700
+48,000
+449% +$791K
DIS icon
109
Walt Disney
DIS
$165B
$1.05M 0.12%
10,690
-488
-4% -$48.8K
ESRX
110
DELISTED
Express Scripts Holding Company
ESRX
$1.03M 0.11%
13,655
-600
-4% -$44.1K
BAC icon
111
Bank of America
BAC
$435B
$1.02M 0.11%
77,147
-550
-0.7% -$7.73K
FRD icon
112
Friedman Industries
FRD
$253M
$1.01M 0.11%
173,786
-2,634
-1% -$15.6K
UNP icon
113
Union Pacific
UNP
$183B
$1M 0.11%
11,501
+8,000
+229% +$676K
BMY icon
114
Bristol-Myers Squibb
BMY
$127B
$938K 0.1%
12,755
-1,000
-7% -$70.7K
OME
115
DELISTED
Omega Protein
OME
$938K 0.1%
46,900
-2,100
-4% -$39.2K
HCSG icon
116
Healthcare Services Group
HCSG
$1.56B
$935K 0.1%
22,600
-250
-1% -$9.6K
GIS icon
117
General Mills
GIS
$19.2B
$906K 0.1%
12,700
-150
-1% -$9.55K
PEG icon
118
Public Service Enterprise Group
PEG
$39.8B
$903K 0.1%
19,366
-26
-0.1% -$1.18K
FWONK icon
119
Liberty Media Series C
FWONK
$24.3B
$887K 0.1%
48,346
-225,642
-82% -$4.39M
DGX icon
120
Quest Diagnostics
DGX
$25.1B
$869K 0.1%
10,680
-150
-1% -$11.4K
T icon
121
AT&T
T
$165B
$868K 0.1%
26,582
-8,664
-25% -$258K
MDY icon
122
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27B
$838K 0.09%
3,080
-50
-2% -$13.4K
C icon
123
Citigroup
C
$222B
$826K 0.09%
19,485
-200
-1% -$8.84K
SYF icon
124
Synchrony
SYF
$23.7B
$825K 0.09%
32,625
+7,500
+30% +$218K
NCLH icon
125
Norwegian Cruise Line
NCLH
$8.89B
$793K 0.09%
19,900
+14,400
+262% +$686K

Similar funds

Shufro Rose & Co's Q2 2016 Portfolio in Review

As of Q2 2016, Shufro Rose & Co held 285 positions worth $904M, up 1% from $895M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Shufro Rose & Co's Q2 2016 filing shows 14 new, 34 increased, 142 reduced and 18 closed positions. Its largest new stake was Allergan plc: 87,846 shares worth $20.3M. The largest sale was Liberty Media Series C, an estimated $4.39M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Shufro Rose & Co's largest Q2 2016 buy was Allergan plc: 87,846 shares worth $20.3M.
  • Shufro Rose & Co added most to Chicago Bridge & Iron Nv in Q2 2016, an estimated $4.45M increase.
  • Shufro Rose & Co's biggest Q2 2016 reduction was Liberty Media Series C, cutting an estimated $4.39M.
  • Shufro Rose & Co fully exited SANDISK CORP in Q2 2016, selling an estimated $4.03M.
  • Shufro Rose & Co's ten largest holdings make up 31% of its $904M portfolio in Q2 2016.
  • Shufro Rose & Co opened 14 new positions and closed 18 in Q2 2016.
  • Shufro Rose & Co's portfolio value rose 1% quarter-over-quarter to $904M.

Based on Shufro Rose & Co's 13F filing for Q2 2016, filed 5 Aug 2016.